Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.
Innate Immunotherapeutics of Australia is the biopharmaceutical company at the center of the insider trading charges leveled against New York Rep. Chris Collins.
Small and mid-cap biotech firms are driving innovation in the sector. Experts explain why investors should take notice.
Shares fell on Friday morning despite positive results for the second quarter.
Shares have fallen more than 11% Thursday despite BAN2401 results showing improvement in reducing the rate of cognitive decline.
Shares fell by more than 11% in after hours trading Wednesday.
The biotech giant will present detailed results of its mid-stage trials of BAN2401 at the Alzheimer's Association International Conference in Chicago.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.